交易 Bristol Myers BMY

BristolMyers實時圖表

金融工具基礎知識

Weekly Search
Weekly
Daily
日期 關閉 更改 更改(%): 開倉

BristolMyers 新聞

黃達傑 2025 Sep 29, 16:00

SOFI 股票預測:未來五年 SoFi 股票會在哪裡?

黃達傑 2025 Sep 29, 16:00

NIO 股票預測:NIO 今天下跌 5%,未來會怎樣?

張瑋庭 2025 Sep 29, 15:10

聯準會獨立性受壓:政治與權力鬥爭

盧昕穎 2025 Sep 29, 14:10

PIMCO 執行長警告川普關稅,強調資料中心商機

張瑋庭 2025 Sep 29, 13:10

金價飆升:各國央行與 ETF 成為主要推動力量

盧昕穎 2025 Sep 29, 10:10

聯準會降息能解就業市場之困? 剖析經濟逆風下的挑戰

黃達傑 2025 Sep 27, 16:00

比特幣價格預測:如何在台灣購買比特幣?

黃達傑 2025 Sep 23, 16:00

Fintech 股票值得關注:Nu Holdings(NU)股票、SOFI 股票

黃達傑 2025 Sep 21, 16:00

QBTS 股票今天上漲 11%:D-Wave Quantum Inc. 發生了什麼事?

黃達傑 2025 Sep 17, 16:00

最佳成長科技股票:CoreWeave (CRWV)、Salesforce (CRM)、Google、Nvidia

最新新聞

顯示更多
許景桓 2025 Sep 30, 01:20

潛在的政府關閉威脅美國關鍵經濟數據的延遲發布

許景桓 2025 Sep 29, 14:20

川普擬對外國電影徵收100%關稅:好萊塢的未來岌岌可危?

盧昕穎 2025 Sep 29, 10:20

克里夫蘭聯準銀行哈瑪克:通膨恐延至2028,呼籲維持限制性政策

陳昊然 2025 Sep 29, 06:20

巴菲特指標飆升至歷史新高:市場估值引發擔憂

林芷柔 2025 Sep 29, 04:20

美國亞洲盟友對投資承諾猶豫不決:南韓和日本重新評估

陳昊然 2025 Sep 29, 03:20

美國國債殖利率在聯準會政策不確定性與政府關門風險中前行

盧昕穎 2025 Sep 29, 02:20

納坦雅胡與川普會面:加薩和平新方案擺上檯面

許景桓 2025 Sep 29, 01:20

聯準會主席繼任:華勒 vs. 哈塞特 - 經濟學家的願望與政治現實

聯絡方式

點差

0.29

點差(%)

0.6412 %

槓桿

1:10

隔夜利息(買入)

-0.0597 %

隔夜利息(賣出)

-0.0292 %

貨幣

USD

交易時間

市場關閉

星期一

13:31 - 19:59

星期二

13:31-19:59

星期三

13:31-19:59

星期四

13:31-19:59

星期五

13:31-19:59

分析與統計

開倉

---

上一次平倉

---

52 週高點/低點

--- – ---

市值

92510560256

流通股份

2035435838

收益日期(下一個)

2001-08-07

現金殖利率 

2025-11-03

除息日

2025-10-03

遠期年股息率

2.48

遠期年現金殖利率

0.0542

每股盈餘

2.49

了解有關此金融工具的詳細資訊

Bristol Myers Bristol-Myers Squibb Company
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.

相關工具

資產
出售
購買
更改(%):
查看所有金融工具

最新教育文章

顯示更多
黃達傑 2025 Sep 29, 16:00

Intel 股票今天上漲 4%:如何在台灣交易 INTC 股票 CFD

黃達傑 2025 Sep 29, 16:00

外匯投資解釋:EUR/USD、USD/JPY、GBP/USD、USD/CAD

黃達傑 2025 Sep 27, 16:00

新加坡股市行情實時分析:新加坡有哪些藍籌股?

Trustpilot